The introduction of Kasai portoenterostomy has dramatically improved the management and survival of children with biliary atresia. The success rate of this operation worldwide varies with different centers. In this respect, many authors have studied the correlation of a successful outcome with various factors, such as the experience and workload of the surgical center, the use of postoperative steroids, the underlying biliary anatomy, as well as the age of patients at the time of the operation. Indeed, the age of 60 days has been used by clinicians as a critical time beyond which the rate of success of the Kasai operation markedly reduces. Despite this worldwide adoption, clear evidence supporting this critical operative time is still lacki...
Copyright © 2015 Naruhiko Murase et al. This is an open access article distributed under the Creativ...
Biliary atresia is the most frequent cause of chronic cholestasis in infants. When left untreated, t...
Background: Biliary Atresia (BA) is worldwide the leading cause of end-stage liver disease in childr...
BACKGROUND: Increased age at surgery has a negative impact on results of the Kasai operation for bil...
OBJECTIVES: The prognosis of hepatoportoenterostomy (the Kasai operation) for biliary atresia worsen...
OBJECTIVE: The prognosis of patients with biliary atresia undergoing Kasai portoenterostomy is relat...
Objective: The Kasai portoenterostomy has been accepted as the primary therapeutic treatment for bil...
The purpose of this study is to review the short-term outcome of patients with biliary atresia (BA) ...
PurposeThe purpose of this study was to investigate factors impacting transplant-free survival among...
The objective. To analyze early and long-term results of surgical treatment of biliary atresia in ch...
Kasai portoenterostomy has been the treatment of choice for neonates with biliary atresia since its ...
Biliary atresia (BA) remains one of the most challenging conditions in paediatric surgery. It has se...
The Korean Association of Pediatric Surgeons (KAPS) performed the second nationwide survey on biliar...
Objective: To analyze the age at surgery for childrenwith biliary atresia and their survival periods...
The prognostic factors for extrahepatic biliary atresia (EHBA) after Kasai portoenterostomy include ...
Copyright © 2015 Naruhiko Murase et al. This is an open access article distributed under the Creativ...
Biliary atresia is the most frequent cause of chronic cholestasis in infants. When left untreated, t...
Background: Biliary Atresia (BA) is worldwide the leading cause of end-stage liver disease in childr...
BACKGROUND: Increased age at surgery has a negative impact on results of the Kasai operation for bil...
OBJECTIVES: The prognosis of hepatoportoenterostomy (the Kasai operation) for biliary atresia worsen...
OBJECTIVE: The prognosis of patients with biliary atresia undergoing Kasai portoenterostomy is relat...
Objective: The Kasai portoenterostomy has been accepted as the primary therapeutic treatment for bil...
The purpose of this study is to review the short-term outcome of patients with biliary atresia (BA) ...
PurposeThe purpose of this study was to investigate factors impacting transplant-free survival among...
The objective. To analyze early and long-term results of surgical treatment of biliary atresia in ch...
Kasai portoenterostomy has been the treatment of choice for neonates with biliary atresia since its ...
Biliary atresia (BA) remains one of the most challenging conditions in paediatric surgery. It has se...
The Korean Association of Pediatric Surgeons (KAPS) performed the second nationwide survey on biliar...
Objective: To analyze the age at surgery for childrenwith biliary atresia and their survival periods...
The prognostic factors for extrahepatic biliary atresia (EHBA) after Kasai portoenterostomy include ...
Copyright © 2015 Naruhiko Murase et al. This is an open access article distributed under the Creativ...
Biliary atresia is the most frequent cause of chronic cholestasis in infants. When left untreated, t...
Background: Biliary Atresia (BA) is worldwide the leading cause of end-stage liver disease in childr...